Uli C. Broedl
Impact in
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes Treatment and Management
- Diabetes Management and Research
- Nephrology top 0.1%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes Treatment and Management 79
- Diabetes Management and Research 36
- Diabetes, Cardiovascular Risks, and Lipoproteins 8
- Surgery 68
- Pancreatic function and diabetes 59
- Co-authors
- Odd Erik JohansenBernard ZinmanChristoph WannerMichaela MattheusSilvio E. InzucchiJohn M. LachinDavid FitchettHans J. Woerle
- Journals
- Diabetes Obesity and Metabolism (12 papers)Diabetes Care (11 papers)Clinical Therapeutics (11 papers)Cardiovascular Diabetology (9 papers)Circulation (5 papers)
- Partner nations
- GermanyUnited StatesCanada
In The Last Decade
Uli C. Broedl
116 papers receiving 22.5k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Endocrinology, Diabetes and Metabolism 18.6k
- Nephrology 2.5k
- Surgery 9.2k
- Cardiology and Cardiovascular Medicine 4.2k
- Pharmacology 2.6k
Countries citing papers authored by Uli C. Broedl
This map shows the geographic impact of Uli C. Broedl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uli C. Broedl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uli C. Broedl more than expected).
Fields of papers citing papers by Uli C. Broedl
This network shows the impact of papers produced by Uli C. Broedl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uli C. Broedl. The network helps show where Uli C. Broedl may publish in the future.
Co-authors
The 25 scholars most cited alongside Uli C. Broedl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 12 | |
| 2 | Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease Hit paper breakdown → | 2017 | 340 |
| 3 | 2017 | 51 | |
| 4 | 2017 | 36 | |
| 5 | 2017 | 1 | |
| 6 | 2016 | 0 | |
| 7 | 2015 | 244 | |
| 8 | 2015 | 21 | |
| 9 | 2015 | 101 | |
| 10 | 2014 | 27 | |
| 11 | 2014 | 173 | |
| 12 | Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus Hit paper breakdown → | 2013 | 976 |
| 13 | 2012 | 30 | |
| 14 | 2009 | 62 | |
| 15 | 2009 | 1 | |
| 16 | 2008 | 27 | |
| 17 | 2004 | 42 | |
| 18 | 2003 | 22 | |
| 19 | 2003 | 50 | |
| 20 | 2002 | 89 |
About Uli C. Broedl
Uli C. Broedl is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Nephrology, Cardiology and Cardiovascular Medicine and Health Informatics, having authored 118 papers that have together received 23.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (79 papers), Pancreatic function and diabetes (59 papers), Diabetes Management and Research (36 papers), Metabolism, Diabetes, and Cancer (35 papers), Lipid metabolism and disorders (10 papers), Chronic Kidney Disease and Diabetes (9 papers), Adipokines, Inflammation, and Metabolic Diseases (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (18.6k citations), Nephrology (2.5k citations), Surgery (9.2k citations), Cardiology and Cardiovascular Medicine (4.2k citations) and Pharmacology (2.6k citations). Uli C. Broedl has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Odd Erik Johansen, Bernard Zinman, Christoph Wanner, Michaela Mattheus, Silvio E. Inzucchi, John M. Lachin, David Fitchett, Hans J. Woerle, Hans J. Woerle and Stefan Hantel. Their work appears in journals such as Diabetes Obesity and Metabolism, Diabetes Care, Clinical Therapeutics, Cardiovascular Diabetology and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.